A Microdosing Study with 99mTc-PHC-102 for the SPECT/CT Imaging of Primary and Metastatic Lesions in Renal Cell Carcinoma Patients.

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Oana C KultererAlexander R Haug

Abstract

99mTc-PHC-102 is a 99mTc-labeled derivative of acetazolamide, a high-affinity small organic ligand of carbonic anhydrase IX (CAIX). 99mTc-PHC-102 has previously shown favorable in vivo biodistribution properties in mouse models of CAIX-positive clear cell renal cell carcinoma (ccRCC) and colorectal cancer. In this study, we aimed to explore the targeting performance of 99mTc-PHC-102 in SPECT in patients with renal cell carcinoma while also assessing the safety and tolerability of the radiotracer. Methods: We studied 5 patients with localized or metastatic ccRCC in a microdosing regimen, after the administration of a 50-μg total of CAIX ligand and 600-800 MBq of 99mTc-PHC-102. Tissue distribution and residence time in normal organs and tumors were analyzed by serial SPECT/CT scans at 3 time points (30 min, 2 h, and 6 h) after intravenous administration. Results: In the 5 patients studied, 99mTc-PHC-102 was well tolerated and no study drug-related adverse events were recorded. In the stomach, kidneys, and gallbladder, the radiotracer showed a rapid initial uptake, which cleared over time. Localization of the study drug in primary tumors of 5 patients was observed, with favorable tumor-to-background ratios. 99mTc-PHC-102 SPECT/CT ...Continue Reading

References

Nov 5, 1997·Bioconjugate Chemistry·S LiuJ A Barrett
Apr 26, 2002·International Journal of Urology : Official Journal of the Japanese Urological Association·Hideshi MiyakitaSeiei Yasuda
Sep 28, 2002·International Journal of Cancer. Journal International Du Cancer·Laura BorsiLuciano Zardi
Nov 21, 2002·Bioconjugate Chemistry·Christopher P LeamonNikki Douglas
Jul 8, 2003·European Journal of Nuclear Medicine and Molecular Imaging·Nicolas AideDenis Agostini
Aug 30, 2005·Molecular & Cellular Proteomics : MCP·Mathias UhlénFredrik Pontén
Jan 11, 2007·Cancer Research·Mark S DennisRalph Schwall
May 17, 2008·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Ronald E FisherRobert J Amato
Dec 17, 2008·Molecular Cancer Therapeutics·Yanping WangHyung L Kim
Jul 21, 2009·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Ludwig DuboisPhilippe Lambin
Aug 28, 2010·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Manfred JohannsenFilippo de Braud
Oct 27, 2011·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Thomas K EigentlerClaus Garbe
Apr 3, 2012·Expert Opinion on Investigational Drugs·Pamela Pribble, Martin J Edelman
Jul 13, 2012·World Journal of Clinical Oncology·Claudiu T Supuran
Oct 31, 2012·Cancer Imaging : the Official Publication of the International Cancer Imaging Society·Hsin-Yi WangChia-Hung Kao
Dec 6, 2012·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Chaitanya R DivgiPaul Russo
Jan 11, 2013·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·John A BarrettJohn W Babich
Oct 16, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·R Wendel NaumannRichard A Messmann
Apr 4, 2014·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Mohan DossJian Q Yu
Feb 25, 2015·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Sarah G J A PeetersPhilippe Lambin
Feb 26, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Nikolaus KrallDario Neri
Sep 10, 2016·Molecular Cancer Therapeutics·Samuele CazzamalliDario Neri
Sep 25, 2016·Annals of Oncology : Official Journal of the European Society for Medical Oncology·B EscudierUNKNOWN ESMO Guidelines Committee
Nov 29, 2016·Journal of Controlled Release : Official Journal of the Controlled Release Society·Samuele CazzamalliDario Neri
Jan 1, 2014·Journal of Kidney Cancer and VHL·Asim Amin, Richard L White
Aug 2, 2017·ESMO Open·Alejo Rodriguez-VidaMichiel H Strijbos
Aug 12, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Hendrik RathkeClemens Kratochwil
Apr 25, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Samuele CazzamalliDario Neri

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adenocarcinoma, Clear Cell

Clear Cell Adenocarcinoma is a tumor that arises in the female genital tract and is characterized by cells that appear clear under the microscope. Discover the latest research here.